Company
Par Health
Hazelwood, Missouri-based generics, API and sterile-injectables maker formed from Mallinckrodt's and Endo's combined businesses, completing its spin-off in November 2025.
2 stories
Regulatory News has published 2 stories about Par Health on 10 October 2026, each sourced to the primary record — the regulator’s decision, the company’s filing or its own announcement. This page is generated from that coverage. Last updated 10 October 2026.
This page is generated from Regulatory News’ editorial coverage of Par Health. It is not an advertisement.
